iCad sells Xoft brachytherapy business to Elekta
ICad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million.
Source: massdevice.com
Stay updated with breaking news from John Lapr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ICad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million.
Clinics and cancer patients to benefit through access to wider range of precise and effective brachytherapy cancer treatmentÂ
Brachytherapy is a precise type of radiotherapy that can be used to treat several cancers - News - PharmaTimes